Press release
Entero's Grid AI Announces Major U.S. Expansion and Incoming Leadership to Accelerate AI Infrastructure Strategy
Entero Therapeutics, Inc. ("Entero") today announced that its wholly owned subsidiary, Grid AI, is finalizing the formation of a U.S.-based executive leadership team as the company accelerates its expansion into the rapidly scaling domestic market for AI-ready digital infrastructure and orchestration technologies.Image: https://www.globalnewslines.com/uploads/2025/11/239fa4cafd7b5877510f583eb5a810bb.jpg
Grid AI expects to announce the appointment of a U.S.-based Chief Executive Officer and Executive Chairman in the near term. The incoming leaders are seasoned public-market operators with extensive experience building and scaling global companies in the demand-response, energy-flexibility, and digital-infrastructure sectors. Their backgrounds align directly with Grid AI's mission to deliver integrated AI orchestration, energy-optimization, and intelligent infrastructure-control solutions for hyperscale and enterprise AI deployments.
The leadership expansion comes at a critical moment for the global compute and data-center ecosystem. This week, AMD CEO Dr. Lisa Su forecast that the global data-center market could reach $1 trillion by 2030, driven by unprecedented AI-compute demand. Supporting that growth could require more than 2,000 new data centers worldwide, each needing advanced AI-driven control systems, power orchestration, and real-time energy market optimization-the core capabilities of the Grid AI platform.
"With more than $50 million invested since 2019 to develop, test, and commercialize this autonomous platform, Grid AI is entering a new phase," said Jason Sawyer, CEO of Entero. "Building a dedicated U.S. leadership team enhances our execution capabilities and strengthens our ability to support large-scale AI-driven SaaS deployments across the domestic digital-infrastructure landscape."
Grid AI plans to provide further updates on leadership appointments, commercial initiatives, and its broader U.S. expansion strategy in the coming weeks.
The company's U.S. buildout supports Entero's long-term objective to capture value at the intersection of artificial intelligence, energy systems, and next-generation digital infrastructure.
About Entero Therapeutics, Inc.
Entero Therapeutics, Inc. is a technology company focused on solutions at the intersection of artificial intelligence, energy systems, and digital infrastructure. The company was founded in 2019 and operates through its wholly owned subsidiary, Grid AI. Entero is headquartered in the United States
Media Contact
Company Name: Entero Investor Relations
Contact Person: Jason Sawyer
Email: Send Email [http://www.universalpressrelease.com/?pr=enteros-grid-ai-announces-major-us-expansion-and-incoming-leadership-to-accelerate-ai-infrastructure-strategy]
City: Boca Raton
State: FL
Country: United States
Website: https://enterothera.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Entero's Grid AI Announces Major U.S. Expansion and Incoming Leadership to Accelerate AI Infrastructure Strategy here
News-ID: 4281178 • Views: …
More Releases from Getnews
StarkScapes, LLC Announces Expanded Landscaping and Lawn Services in Louisville, …
Image: https://www.globalnewslines.com/uploads/2025/12/1765806395.jpg
StarkScapes, LLC is a trusted landscaping and outdoor services provider based in Louisville, OH, offering professional lawn care, maintenance, hardscaping, and seasonal services. Known for dependable workmanship and attention to detail, the company enhances residential and commercial properties with reliable, high-quality outdoor solutions.
Louisville, OH - A growing leader in professional outdoor property care, announces expanded service offerings designed to enhance residential and commercial landscapes across the region. With a…
SmartTOP Convertible Top Controller for Range Rover Permanently Reduced in Price
The SmartTOP convertible top controller from manufacturer Mods4cars for the Range Rover Evoque Convertible is now permanently reduced in price. The retrofit convertible top module is now available for 169,00 Euro plus tax. It enables one-touch operation of the convertible top while driving and allows the roof to be opened and closed remotely using the vehicle key fob remote.
Las Vegas, Nevada - December 15, 2025 - Mods4cars has permanently reduced…
Bloomly Kids Introduces New Tools to Support School and Daycare Enrollment Growt …
Image: https://www.globalnewslines.com/uploads/2025/12/1765760392.jpg
The early education marketing solutions provider helps schools and daycares attract more families and streamline operations.
Los Angeles, CA - Bloomly Kids, a leading provider of early education marketing solutions [https://www.bloomlykids.com/], today announced new initiatives designed to help schools and daycares across the U.S. boost enrollment and improve family engagement. Since 2018, the company has supported thousands of institutions, from small daycare centers to large preschools, in achieving measurable growth…
Funeral Director Ronald Moy Death Calls for Stronger Community Support Around Gr …
Image: https://www.globalnewslines.com/uploads/2025/12/1765836081.jpg
Ronald Moy, Escondido California
Escondido leader urges residents to take simple steps to support neighbours coping with loss
Following his recent in-depth interview, long-time funeral director Ronald Moy is calling for greater community involvement in grief awareness and support. With more than twenty years of experience guiding families through bereavement, Moy says the public often underestimates the long-term effects of loss - and the role everyday people can play in easing…
More Releases for Entero
Celiac Disease Treatment Market Set for Robust Growth Through 2034, Driven by Re …
The celiac disease treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, including Entero Therapeutics, Amgen/Provention Bio, Takeda, and Sanofi, among others.
DelveInsight's "Celiac Disease Market Insight, Epidemiology And Market Forecast - 2034" report delivers an in-depth understanding of the celiac disease treatment market, historical and forecasted epidemiology, as well as market trends across the US, EU4 (Germany, France,…
Celiac Disease Pipeline 2025: Groundbreaking Clinical Advancements by 80+ Global …
DelveInsight's Celiac Disease Pipeline Insight, 2025 report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Celiac Disease pipeline landscape. It covers the Celiac Disease Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Celiac Disease Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Celiac Disease Pipeline products in this space.
DelveInsight's "Celiac Disease…
Gastroparesis Pipeline Drugs 2025 Report by DelveInsight: Strategic Intelligence …
DelveInsight's, "Gastroparesis Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Gastroparesis pipeline landscape. It covers the Gastroparesis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gastroparesis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Gastroparesis…
Celiac Disease Pipeline 2025: Groundbreaking Clinical Advancements by 80+ Global …
With Celiac Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand for safer, more effective treatment options. According to DelveInsight, the Celiac Disease pipeline comprises 25+ pharmaceutical and biotech companies actively developing 30+ therapeutic candidates targeting Celiac Disease. These therapies span various stages of clinical and non-clinical development, underscoring the intense innovation and commitment to…
Gastroparesis Pipeline Appears Robust With 8+ Key Pharma Companies Actively Work …
DelveInsight's, "Gastroparesis Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Gastroparesis pipeline landscape. It covers the Gastroparesis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gastroparesis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Gastroparesis…
Celiac Disease Pipeline: Pioneering Progress with 25+ Leading Companies Developi …
The Celiac Disease market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Sanofi, Entero Therapeutics, Takeda, Pfizer, Topas Therapeutics, Anokion SA, Protagonist Therapeutics, and Equillium. These industry pioneers are transforming treatment strategies and redefining the future of Celiac Disease, bringing new hope to patients worldwide.
DelveInsight's "Celiac Disease Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Celiac…
